Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05220202 · ClinicalTrials.gov registry record · NA

MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression

A NA study of Depression and Aging, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
264
Enrollment target
2
Study locations

NCT05220202 is a NA study of Depression and Aging that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 264 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (66% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05220202, a NA study of Depression and Aging, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
264 participants
Enrollment target
2
Study locations

Study Summary

The proposed study seeks to evaluate effectiveness, implementation processes, and cost of MOTIVATE among older Veterans with chronic musculoskeletal (MSK) pain and comorbid depressive symptoms.

Interventions

  • BEHAVIORAL Behavioral Intervention Group (MOTIVATE)

Study Locations (2)

Texas

  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX - Dallas
  • Michael E. DeBakey VA Medical Center, Houston, TX - Houston

Trial Details

FieldValue
Enrollment Target 264 participants
Start Date 2023-09-20
Est. Completion 2026-12-01
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05220202

The ClinicalTrials.gov registry entry for NCT05220202 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 264 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (66% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Behavioral Intervention Group (MOTIVATE) is the first listed.

NCT05220202 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05220202 about?

NCT05220202 is a clinical study titled "MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression". The proposed study seeks to evaluate effectiveness, implementation processes, and cost of MOTIVATE among older Veterans with chronic musculoskeletal (MSK) pain and comorbid depressive symptoms.

What is the current status of trial NCT05220202?

This trial is currently recruiting. It is a NA study. The enrollment target is 264 participants. The study started on 2023-09-20. Estimated completion is 2026-12-01.

What conditions does trial NCT05220202 study?

This clinical trial studies the following conditions: Depression, Aging, Musculoskeletal Pain, Chronic Back Pain.

What interventions are being tested in trial NCT05220202?

The interventions under investigation include: Behavioral Intervention Group (MOTIVATE) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05220202?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05220202 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.